Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
RBC Capital Downgrades Concordia Healthcare (CXRX) to Sector Perform
November 8, 2016 6:20 AM ESTRBC Capital downgraded Concordia Healthcare (NASDAQ: CXRX) from Outperform to Sector Perform with a price target of $2.50 (from $10.00) as the US Legacy business significantly underperformed largely due to pricing issues.
Analyst Douglas Miehm commented, "are downgrading Concordia to Sector perform as we believe risks are increasing materially and visibility is worsening. In... More
Concordia International (CXRX) Misses Q3 EPS by 35c; Guidance Suspended
November 7, 2016 7:06 AM ESTConcordia International (NASDAQ: CXRX) reported Q3 EPS of $0.69, $0.35 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $185.5 million versus the consensus estimate of $206 million.
Concordia is suspending guidance as the Company assesses the business under new leadership
The Company commented, "Concordia's... More
